No abstract available
MeSH terms
-
Aged
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / classification
-
Antipsychotic Agents / therapeutic use*
-
Aripiprazole
-
Basal Ganglia Diseases / chemically induced
-
Basal Ganglia Diseases / diagnosis
-
Benzodiazepines / therapeutic use
-
Clozapine / therapeutic use
-
Diagnosis, Differential
-
Female
-
Humans
-
Metabolic Syndrome / chemically induced
-
Middle Aged
-
Olanzapine
-
Pain / etiology
-
Pain / prevention & control
-
Patient Compliance
-
Peripheral Nervous System Diseases / diagnosis
-
Peripheral Nervous System Diseases / drug therapy
-
Piperazines / therapeutic use
-
Quinolones / therapeutic use
-
Schizophrenia, Paranoid / complications
-
Schizophrenia, Paranoid / diagnosis*
-
Schizophrenia, Paranoid / drug therapy*
-
Skin Diseases, Parasitic / diagnosis*
-
Sleep Wake Disorders / chemically induced
Substances
-
Antipsychotic Agents
-
Piperazines
-
Quinolones
-
Benzodiazepines
-
Aripiprazole
-
Clozapine
-
Olanzapine